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Abstract: Preterm birth is an obstetric condition associated with a high risk of infant mortality
and morbidities in both the neonatal period and later in life, which has also a significant public
health impact because it carries an important societal economic burden. As in many cases the
etiology is unknown, it is important to identify environmental factors that may be involved in the
occurrence of this condition. In this review, we report all the studies published in PubMed and
Scopus databases from January 1992 to January 2019, accessible as full-text articles, written in English,
including clinical studies, original studies, and reviews. We excluded articles not written in English,
duplicates, considering inappropriate populations and/or exposures or irrelevant outcomes and
patients with known risk factors for preterm birth (PTB). The aim of this article is to identify and
summarize the studies that examine environmental toxicants exposure associated with preterm birth.
This knowledge will strengthen the possibility to develop strategies to reduce the exposure to these
toxicants and apply clinical measures for preterm birth prevention.
Keywords: air pollution; environmental toxicants; environmental exposure; particulate matter;
drinking water contaminant; tobacco smoke; polycyclic aromatic hydrocarbons; pregnancy outcomes;
preterm birth; obstetrical complications
1. Introduction
Preterm birth (PTB) is defined as a delivery that occurs before 37 weeks of pregnancy. It can be
one of the most important causes of mortality and morbidity in newborns, particularly in the case
of very early PTB occurring before 32 weeks of pregnancy. Many studies have shown that PTB can
be associated with several problems in lung and neurological development [1–4]. PTB represents
a worldwide health problem. Unfortunately, its etiology is multifactorial and, in most cases, remains
poorly understood. PTB risk factors are classified as modifiable factors (anemia, smoking, physical
activity, prenatal care, nutrition, infections, obesity, and exposure to pollutants) and non-modifiable
factors like phenotypic and genotypic ones.
PTB is caused by several factors such as: demographic factors, genetic predisposition, nutritional
status, pregnancy history, and comorbidity (diabetes mellitus and hypertension/preeclampsia),
infections, cervical dysfunction, placental abruption, uterine overdistention, fetal intrauterine growth
restriction (polyhydramnios or multifetal pregnancy) [5]. In this wide range of risk factors, exposure
to environmental pollutants during pregnancy has received increasing interest from researchers,
and many studies have analyzed the relationship between environmental contaminants and the risk of
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PTB [6]. In fact, environmental pollutants (pesticides, polycyclic aromatic hydrocarbons, particulate
matter, and toxic metals) could influence the pathogenesis of PTB [5,7].
This systematic review will identify and summarize the published studies on the possible role of
environmental toxicants exposure in PTB. This knowledge will strengthen the possibility to identify
pollutants that may be involved in PTB etiology in order to elaborate strategies to reduce such exposure
and implement clinical measures for PTB prevention.
2. Materials and Methods
2.1. Search Strategy
We conducted a literature search in PubMed and Scopus databases identifying articles published
from 1 January 1992 to January 2019 on the exposure to toxicants and the occurrence of PTB.
We used any combination of the following key words: air pollution OR environmental toxicants
OR environmental exposure OR particulate matter OR drinking water contaminant OR persistent
organic pollutants OR non-persistent chemicals OR polycyclic aromatic hydrocarbons OR toxic metals
OR tobacco smoke OR electronic cigarettes OR global warming AND pregnancy outcomes OR preterm
birth OR obstetrical complications OR birth weight.
2.2. Inclusion Criteria
Studies were included if they described exposure to environmental toxic compounds in the mother
or gestational compartment (e.g., amniotic fluid, umbilical cord blood, or placental tissue) during
pregnancy and if they analyzed differences in these levels among preterm delivery subjects compared
to term delivery subjects. We considered accessible full-text articles written in English, clinical studies,
original studies, and reviews. We examined the evidence of the association between environmental
contaminants and preterm birth across the studies and we grouped them by type of contaminant (air
pollutants, organic pollutants, toxic metals, tobacco, e-cigarette, and global warming).
This protocol was developed according to the reporting guidelines established by the Preferred
Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) 2009.
2.3. Exclusion Criteria
The studies were excluded if they were: not written in English, OR duplicates OR irrelevant
population OR Irrelevant exposures OR irrelevant outcomes OR patients with known risk factors
for PTB.
Therefore, from 351 records identified through database synthesis, we included 78 studies in the
qualitative synthesis.
3. Results
3.1. Environmental Compounds
3.1.1. Air Pollutants
Air pollution represents one of the most important environmental risk factors for human health;
the only way to avoid related clinical effects is to reduce the levels of exposure. The negative effects on
health comprise a wide range of clinical outcomes, from general discomfort (burning eyes, allergies) to
hospitalization for respiratory diseases, lung cancer, and death [8–10].
Air pollution can be generally defined as the presence of a complex mixture of gases (e.g., carbon
monoxide [CO], nitrogen monoxide [NO], nitrogen dioxide [NO2], sulphur dioxide [SO2], ozone [O3],
particles [solid or liquid]) which are released directly from various sources or formed by the interaction
of the primary pollutants in the atmosphere [11].
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The relationship between air pollution and obstetric complications has received great attention;
in fact, epidemiological evidence has shown significant association between air pollution exposure
during pregnancy and adverse gestational outcomes, such as low birth weight (LBW), intrauterine
growth restriction (IUGR), and PTB [12–14]. Moreover, preterm newborns could have severe
respiratory, cardiovascular, and neurodevelopmental disorders [15]. The physiopathological base
of these associations is not fully understood, but inflammation and oxidative stress seem to play
an important role [16]. Air pollutants could alter alveolar cell differentiation and maturation leading to
neonatal respiratory distress syndrome and reactive airway disease [17]. During pregnancy, the oxygen
demand is higher, the ventilation rate increases, and a faster fat accumulation process could lead to the
accumulation of pollutants. In addition, as a result of toxics competition with hemoglobin binding
sites, O2 availability to the fetus can be reduced, negatively affecting their development [17].
Particulate Matter (PM)
PM is composed of several chemical species, classified according to their aerodynamic diameter
in PM10 (mass concentration in the atmosphere of particles with an aerodynamic diameter < 10 µm)
and PM2.5 (aerodynamic diameter < 2.5 µm). Their composition and size are strongly related to their
toxicity: the smaller the particles, the major their toxic effects because of their capacity to penetrate deep
in regions of the lung and to translocate to the systemic circulation [18]. Exposure during pregnancy is
associated with elevated blood pressure and high risk of pre-eclampsia [19]. A meta-analysis conducted
by Liu et al. in 2017 reported that exposure to PM2.5 during pregnancy represents an important risk
factor for PTB [20].
Polycyclic Aromatic Hydrocarbons (PAHS)
PAHs represent a class of substances that are released during combustion processes from vehicles
and industries. The exposure may occur through inhalation. Some authors observed a correlation
between PAHs exposure and PTB [21,22]. Furthermore, Guo et al. in 2012 confirmed these association,
finding a high PAH concentration in umbilical cord blood at birth of newborns as a marker of maternal
exposure [23]. Nevertheless, further research is necessary to find more sensitive serum or urinary
biomarkers of PAHs exposure that can express the degree of inhalation and ingestion [24–26].
3.1.2. Organic Pollutants
Drinking Water Contaminants
Many chemicals can be found in drinking water supplies. The treatment of drinking water
with chlorine leads to the release of disinfection by-products (DBP), such as trihalomethanes (THM:
chloroform, bromoform, bromodichloromethane, and dichlorobromomethane) and haloacetic acids
(HAA: chloroacetic acid, dichloroacetic acid, trichloroacetic acid, bromoacetic acid, and dibromo acetic
acid). The relationship between the exposure to these contaminants and PTB is not clear. Grellier et al.
in 2010 published a meta-analysis of nine studies, showing no significant association with PTB [27–34]
and, on the contrary, a possible a reduction in PTB after THM exposure [35]. Similarly, two of the nine
studies reviewed did not find a significant correlation between the exposure to HAA and PTB [29,33].
In contrast, in line with other studies, an association between small-for gestational-age (SGA) fetuses
and THM exposure during the third trimester was described [36,37].
The difficulties in the evaluation of these results is confirmed by a meta-analysis conducted by
Jaakkola et al., which highlighted, contrary to their initial hypothesis, a reduction in the risk of PTB,
probably due to the protective role played by the residual chlorine of chlorinated water in preventing
maternal infections during pregnancy [38].
The maternal urinary levels of trichloroacetic acid (TCAA) during pregnancy was proposed as
a biomarker of chlorinated water exposure. Furthermore, TCAA urinary levels seem to be a marker
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of long-term ingestion of contaminated water [39]. A study conducted using this biomarker did not
show any significant correlation between maternal urinary levels and PTB [40].
On the other hand, Horton and colleagues (2011) observed an association between DBP exposure
and PTB. In their study THM, HAA, and total organic halide (TOX) were measured in drinking water,
finding a significantly higher incidence of PTB only in mothers with occasional and continuous TOX
exposure [41].
In addition to DBP, chlorinated solvents such as trichloroethylene (TCE) and tetrachloroethylene
(PCE) may be found in drinking water supplies. These solvents can dissolve in water and come into
contact with pregnant women through inhalation of vapors or ingestion. Other authors found no
correlation between exposure to these compounds and PTB [42–44].
Rinsky et al. described an association between atrazine exposure and PTB [45]. Atrazine (6-chloro
N-ethyl-N-(1-methylethyl)-1,3,5-triazine-2,4-diamine), is an herbicide used worldwide to control the
spread of infesting broadleaf and grassy weeds that interfere with the growth of corn, sugar canes,
and other crops. This compound can be present in drinking water and can interfere with endocrine
homeostasis, acting as endocrine disruptor. This study found a higher incidence of PTB in mothers
highly exposed during pregnancy compared to controls [45].
Persistent Organic Pollutants: Organochlorine Compounds (OCPs) and Perfluoroalkylated
Substances (PFAS)
OCPs are ubiquitous toxic chemicals, widely used in industry, agriculture, and food. They are
pesticides, industrial chemicals or by-product of industrial processes or generated by combustion of
organic chemicals. Exposure to them seems to be associated with several reproductive disorders and
gynecological diseases such as endometriosis [46–50].
These substances bioaccumulate in lipid-rich tissues because of their strong lipophilic nature
and low degradation rates. OCPs have been found in different human tissues such as blood,
placental tissue, amniotic fluid, and breast milk. [51]. Exposed mothers could transfer these
chemicals to the fetus and the newborn through placenta, blood, and breast milk. This transfer
was confirmed by several studies [52,53]. Porpora et al. found a strong correlation between
maternal and fetal compartments levels of some polychlorinated biphenyls (PCB 153 and 180),
β-hexachlorobenzene (β HCB), and p,p’-dichlorodiphenyldichloroethylene (p,p’-DDE), a metabolite of
Dichlorodiphenyltrichloroethane (DDT ) [54].
In other studies, higher levels of βHCB were found in maternal and cord blood in cases of PTB
with intact membrane compared to women with full-term babies [55]. The continuous exposure to
these compounds during pregnancy can alter hormonal homeostasis: physiologically, progesterone
promotes uterine quiescence; estrogens, on the other hand, promote myometrial activation with
increased reactivity to uterotonic agents.
OCPs may act as endocrine chemicals disruptor (ECDs) modulating the release, transport,
metabolism, or elimination of natural hormones. In mammalians and fishes, β-HCH, the most
dangerous of Hexachlorocyclohexane (HCH) isomers, acts as a xenoestrogen, activating uterine
contraction with a high risk of PTB [56–58].
Moreover, Tyagi et al. demonstrated that these compounds increase the mRNA expression of genes
involved in inflammatory pathways and prostaglandins, enhancing uterine contractions and cervical
modifications [59]. Furthermore, some authors have shown a relationship between organochlorine and
organophosphate pesticides and neurodevelopmental disorders in infants, which was associated with
a higher incidence of sudden infant death syndrome (SIDS) [60]. Perfluoroalkyl substances (PFAS) are
a family of synthetic compounds composed of a carbon-fluorine backbon. Many PFAS are resistant
to oil and water and therefore useful in the manufacture of stain-resistant products (e.g., carpets and
fabrics), non-stick coatings, and food packaging [61].
A study of De Felip et al. showed higher serum concentrations of perfluorooctane sulfonate
(PFOS) and perfluorooctanoic acid (PFOA) in women with great consumption of beef, pork, lamb,
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ham and salami, fish and seafood. Higher levels of PFOA were also found in women with a diet
rich in cheese, eggs, liver, and vegetables [62]. Sagiv et al. found over two-fold odds of preterm
birth in women with concentrations in the highest quartile of PFOS versus those with concentrations
in the lowest quartile (odds ratio = 2.4, 95% CI: 1.3, 4.4). Odds of preterm birth were weaker for
perfuorononanoate (PFNA) and null for PFOA and perfluorohexane sulfonate (PFHxS) [61].
Non-Persistent Organic Pollutants: Phthalates, Phenols, and Parabens
Phthalates are non-persistent organic pollutants used to increase flexibility in plastics and are
also found in many personal care products and toys. The exposure to these substances is spread
through ingestion, dermal application, and inhalation. They may act as endocrine disruptors [63].
Adibi et al. in 2009 found that i-(2-ethylhexyl) phthalate (DEHP) may interfere with signaling related
to the timing of labor. This compound can cross the placenta, disrupt steroid hormone synthesis,
and activate peroxisome proliferator-activated receptor gamma. However, this study found that
DEHP may have a protective role in PTB occurrence [64]. A Mexican cohort study who compared
third-trimester urinary phthalate metabolite concentrations in 30 women who had PTB (<37 weeks of
gestation) with those of 30 controls (≥37 weeks of gestation) found that phthalate exposure can be
associated with PTB [65]. Ferguson et al., in a case–control study of 130 cases of PTB and 352 controls,
found that women exposed to phthalates early and late in pregnancy had significantly increased risk
of PTB [24,25]. Few years later, the same group conducted other studies on the correlation between
exposure to phthalates, analyzing urinary 8-isoprostane, a marker of oxidative stress, confirming that
PTB was due to the inflammatory effects of these compounds [66,67].
Exposition to phenols and parabens is extremely common as a consequence of their high
distribution in the environment. They are present in food and personal care products, as well as
in many pharmaceutical compounds. Some of the phenols and parabens more frequently present
are bisphenol S (BPS), benzophenone 3 (BP3), triclosan (TCS), triclocarban (TCB), methyl-paraben
(MPB), ethyl-paraben (EPB), propyl-paraben (PPB), and butyl-paraben (BPB). The role of these toxic
compounds in adverse pregnancy outcome is controversial, as they can have a double effect on the
immune system, i.e., a proinflammatory or an anti-inflammatory effect. Aung et al., in 2018, reported
that urinary levels of TCS, 2,5-dichlorophenol (2-5-DCP), and MPB in mothers’ urine is associated
with an increase of IL-6, IL-12, and TNF alpha, probably through the stimulation of the estrogen
receptor, while higher urinary concentrations of EPB and BP3 are associated with lower concentrations
of proinflammatory cytokines [68].
3.1.3. Tobacco Smoke and Electronic Cigarettes Aerosol
Many studies have observed an association between tobacco smoke and PTB [69–72]. Despite the
decreased prevalence over the years of pregnant women smokers, it is estimated that in the future
about 13% of women will still be smoking during pregnancy [73]. Smoking represents one of the
few risk factors that can be controlled; therefore, exposure to it can be reduced during pregnancy.
The law enforcement forbidding smoking in public places contributed to reduce the exposure in the
last few years. However, there are still conflicting data about the relationship between PTB and passive
exposure to tobacco smoke.
Cigarettes contain a series of substances, in addition to nicotine, which can have toxic effects,
such as CO, cyanide, aniline, methanol, hydrogen sulfide, arsenic, lead, cadmium, and other toxins
or carcinogens [74]. These toxins may induce pregnancy disorders through different mechanisms,
described by Goldstein et al. [75]. Smoking causes endothelial damage mediated by oxidative stress,
which can determine vasoconstriction with fetal growth restriction. Moreover, the increase of CO,
with its greater binding affinity for hemoglobin, reduces oxygen diffusion to the fetus [75]. Regarding
PTB, smoking may increase the risk of Preterm Premature Rupture of Membranes (PPROM) [5].
Furthermore, smoking reduces the elasticity of the fetal membranes, with higher risk of their rupture
and PTB [76].
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A meta-analysis conducted by Cui H. et al. in 2016, which included 24 studies involving
5607 women who experienced PTB, found that environmental tobacco passive exposure increases the
risk of PTB between 20% and 16% in the external and domestic environment, respectively [77].
Cigarette smoking during pregnancy is also associated with adverse neonatal outcomes,
with a higher incidence of SIDS [78,79]. A preponderant role in this sense is played by fetal exposure
to nicotine during pregnancy. Evidence suggests that acetylcholine (ACh) has a trophic role in brain
development through a mechanism mediated by ACh receptors. It seems that nicotine can bind these
receptors, causing their abnormal function and expression, with a consequent neuronal damage [60].
The evaluation of tobacco-smoking consequences during pregnancy can be problematic because
of the difficulty in establishing the level of exposure. Many authors proposed different markers such as
cotinine, a metabolite of nicotine [80], that can be measured in serum [81] and in neonatal meconium
and urine [82]; thiocyanate, a metabolite of hydrogen cyanide, rarely used [83], and exhaled carbon
monoxide (CO) levels, measurable by a non-invasive and therefore preferable method [84].
In 2017, Chen et al. conducted a study about the effect of maternal exposure to electronic cigarettes’
compounds during pregnancy using mice models. The use of electronic cigarettes is now widespread,
and their diffusion has been facilitated by the intense advertising campaign to which they have
been subjected. It is common opinion that these cigarettes are harmless, and their use seems to be
frequent among pregnant women, with a percentage of around 15% [85]. In addition to nicotine,
which may be present in these devices, the presence of other toxic compounds in the aerosol of these
cigarettes has been demonstrated. The aim of Chen’s study was to evaluate the effects of maternal
exposure to these aerosols on the fetus, with attention on the possible increase in the expression of
the pro-inflammatory cytokines and the development of the respiratory apparatus in the offspring.
They found that mice exposed to intrauterine e-cigarettes had an increase in pro-inflammatory
cytokines production, independently of nicotine presence in the device, condemning any type of
electronic cigarette. They noticed the involvement of three important markers for lung development:
PDGFa, EphB2, and Sftpc. PDGFa was increased in both e-cigarette exposure groups, with and without
nicotine. Moreover, an abnormal production of pro-inflammatory cytokines in the lung of mothers
and offspring, including IL-1ß, IL-6, and TNFa, has been demonstrated. Finally, abnormalities in DNA
methylation were also found, even if it is not clear which parts of the genome are involved [86]. At the
best of our knowledge, there are not studies about e-cigarettes exposure and the occurrence of PTB.
3.1.4. Toxic Metals
The reproductive and clinical implications of metal exposures are well described by Singh et al. [87].
They observed that the exposure to these substances could have severe consequences on the maternal–fetal
unit as well as on the reproductive system. These metals could be involved in the unregulated production
of free radicals such as reactive oxygen species (ROS) and reactive nitrogen species (RNS) in endothelial
cells. As a result, these interactions could cause damage to DNA, membrane lipids, and enzymes in
placental tissues [87].
Moreover, toxic metals could modify the levels of antioxidant biomarkers, such as glutathione
(GSH), superoxide dismutase (SOD), and catalase, leading to poor pregnancy outcomes, such as fetal
growth restriction, pre-eclampsia, and PTB [88] (Table 1).
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Table 1. Possible effects of exposure to toxic metals during pregnancy.
Toxic Metal Limit Values inDrinking Water (WHO) Source of Exposition Risks of Exposition During Pregnancy
Lead (Pb) 0.05 mg/L Water, food, air, soli, dust
Passive diffusion to placental tissue
• Oxidative stress
• Placental tissue injury
• High rate of preterm delivery
Cadmium (Cd) 0.003 mcg/L
Fiber-rich foods
• Vegetables
• Cereals
• Potatoes
• Spinach
Air pollution
Tobacco smoking
Toxic effect on villous cells with risks of
• IUGR (intrauterine
growth restriction)
• Preterm delivery
• Placental hemorrhage
• Hormonal unbalance
• Genotoxicity
• Fetotoxicity
Mercury (Hg) 1 mcg/L
Food (fish)
Cosmetic preservatives
Insecticides
High binding on placental tissue leads to:
• Oxidative stress
• SGA (small for gestational age)
Arsenic 10 mcg/L
Home tiles
Industry
Agriculture
Anomalous placental vascularization and
oxidative stress:
• Miscarriage
• Stillbirth
• Preterm birth
• Neonatal death
4. Mechanisms Involved
The placental transfer of pollutants could compromise placental function and pregnancy outcomes
directly or indirectly through a wide range of mechanisms:
4.1. DNA Damage
Chemical compounds could bind DNA and form covalent adducts, modifying genic expression
and fetal development [89–91]. Studies on humans have shown that intrauterine exposure to air
pollution is associated with increased levels of DNA adducts in the placenta and in fetal blood [92,93].
4.2. Hypoxia
Low oxygenation can affect intervillous perfusion and alter maternal blood viscosity [94].
This mechanism is well described in several studies: some air pollutants could cause placental
insufficiency and fetal hypoxia diagnosed by an increased value of Lactate dehydrogenase (LDH),
an indirect sign of anaerobic metabolism [95–97]. Fetal hypoxia could cause the inhibition of breathing
movements that can be observed by ultrasound, reduction of the numbers of alveoli, and high airway
resistance [98,99].
4.3. Oxidative Stress
Oxidative stress is caused by an imbalance between the production of ROS and the ability
of antioxidant defenses to neutralize them. It could lead to negative pregnancy and fetal
outcomes [100–102]. This balance is well controlled by nitric oxide that, through the action of SOD,
can inactivate superoxide anions. Inflammation could produce superoxide and nitric oxide, and these
two species react to form peroxynitrite; the latter compound is involved in lipid peroxidation and DNA
damage, and its toxic activity is shown by the presence of nitrotyrosine residues. In several gestational
diseases, high levels of oxidative species are confirmed by the presence of these compounds in placental
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tissues. These substances could affect placental function, in particular trophoblast proliferation and
differentiation, increasing vascular reactivity [103], with poor fetal outcomes. Many environmental
compounds can cause cellular oxidative stress, with consequent alteration of the integrity of the
amniochorial membrane and/or activation of cervical ripening, a prelude to PTB occurrence [104–107].
4.4. Inflammation
Toxic compounds could also activate inflammatory pathways, with severe consequences for
pregnancy [108,109] and fetal development disorders [110]. Nachman et al. 2016 found a positive
relationship between maternal PM2.5 exposure before and during pregnancy and intrauterine
inflammation [111]. Furthermore, it has been demonstrated that PM2.5 exposure in rats during
pregnancy may induce inflammation in the placenta [112]. Moreover, PM2.5 may be associated with
intrauterine inflammation (IUI), one of the most relevant risk factors for PTB [113–115].
4.5. Epigenetic Changes
Environmental pollutants could change genic expression through epigenetic changes
(post-translational modifications) such as DNA methylation and acetylation and ubiquitination and
histone modifications [116–118]. Several studies have shown that maternal toxic exposure correlates
to a reduction of placental methylation [119,120]. Air pollution exposure could lead to epigenetic
alterations of genes related to the inflammatory pathway [121].
5. Not Only Environmental Toxic Compounds: The Role of Global Warming
In the last years, there has been an increasing interest in global warming, both in terms of the
impact on the environment and in terms of the impact on human health. Many authors conducted
studies about the correlation between global warming and the occurrence of unfavorable pregnancy
outcomes, like PTB [122–125].
Zhong et al., in 2018, performed a cohort study to determine the critical period of heat exposure
during pregnancy in the occurrence of PTB. The authors found an increased risk of PTB proportional to
the time of exposition especially in warm seasons, with a major risk with exposure during the second
trimester of pregnancy [126]. Conversely, another review of the literature reported that both heat and
cold are associated to higher risk of PTB [127].
As of the window of exposure, a recent study across 12 U.S.A. cities reported a major effect for
heat and cold especially during the first seven weeks of gestation for cold and during weeks 15–21 for
heat [123].
In addition to these findings, Guo et al. demonstrated a critical window also during the
pre-gestational period. Moreover, they found that exposure to cold temperatures in the last third
trimester before pregnancy has a protective role. The underlying mechanism of this association remains
unclear. It has been assumed that heat exposure may lead to acute stress, with blood flow reduction to
the uterus and onset of contractions due to a massive release of oxytocin [128].
6. Discussion
Over the last few years, we have witnessed an increase in the incidence of PTB. The PTB syndrome
represents a worldwide problem, and the comprehension of the underlying mechanisms is necessary
in order to prevent it, when possible, and to offer to mother and fetus a better treatment to reduce
the related complications. In order to develop the PTB syndrome, three factors are necessary: a valid
uterine contractile activity, cervical ripening, and amniotic membranes activation followed by their
preterm rupture (PPROM). The cause of PTB is not always clear. The most commonly described
causes of PTB are related to infectious and inflammatory factors. Inflammation and the activation
of inflammatory cytokines play a fundamental role in PTB, and it seems that exposure to chemical
compounds and pollutants may be associated with this obstetric complication precisely through the
activation of inflammatory cytokines. Available data on the role of environmental pollutants in the
Toxics 2019, 7, 11 9 of 16
occurrence of PTB provide conflicting results. Data cannot be well compared because of different study
designs, analytic methods, and geographical areas where the studies were carried out.
Therefore, the relationship between environmental pollutants and PTB remains unclear. However,
there are some mechanisms that may explain the role of these substances as risk factors for PTB, such as
competition with hemoglobin binding sites reducing O2 availability by air pollutants [17]—with
consequent fetal growth restriction and fetal distress, which can lead to the activation of labor via the
cortisol axis—capability of PM to affect the hemodynamic system through different pathways [129],
placental damage, with unregulated production of free radicals such as ROS and RNS in the placental
tissue due to the presence of toxic metals [88].
OCPs seem to be able to alter hormonal homeostasis acting as endocrine disruptors.
The involvement of the estrogen receptor, of the immune system, and consequently of inflammatory
factors are also implicated as the mechanisms of action of phenols and parabens [68]. Despite some
POPs are either banned or restricted under the “Stockholm Convention on POPs’ of 2001, entered
into force on 17 May 2004, they continue to be present all over the world. In fact, in some countries,
these substances are still produced, causing a worldwide exposure which occurs mainly through the
food chain. Among all European countries, Italy seems to be the country with the lowest exposure
rate, probably due to a greater use of local products [130].
Conversely, despite the initial hypotheses, a significant correlation between preterm birth
syndrome and drinking water contaminants such as the by-products DBP, THM, and HAA has not
been demonstrated, while an association has been described with chlorinated solvents and atrazine,
acting on hormone receptors [35,41,45].
It is worth noting that a different role in causing PTB is played by global warming. Particularly,
it seems that higher temperatures can lead to oxytocin’s release and onset of uterine contractions.
The underlying mechanisms are still unclear. In preventing global warming, an important role is
played by green spaces and vegetation. Vegetation influences ambient temperature through different
mechanisms as the photosynthesis process, in which part of solar radiation is absorbed, and only
a small part is stored as heat. Also, vegetation can modify air movement. For these reasons, a
recommended approach could be to increase green areas near urban areas to induce cooling [131].
In conclusion, pollutants seem to influence the occurrence of PTB (Table 2); however, it is
very difficult to identify and quantify their role because of conflicting results in the available
studies. Nevertheless, being the relationship between PTB syndrome and environmental pollutants
an important issue, further studies are sorely needed to standardize exposure analytic methods and to
improve comparability.
Table 2. Studies on environmental chemical exposure and preterm birth. PCB, polychlorinated
biphenyls; PPROM, Preterm Premature Rupture of Membranes.
Class of Toxic Chemicals Compounds References Findings
Air pollutants CO, NO, NO2, SO2, O3
Parker JD 2011 [13], Shah PS 2011 [14],
Estarlich M 2015 [15], Fleisher NL 2014 [16],
Pike K 2012 [17]
Significant association
with adverse
gestational outcomes
Particulate matters Toxics with aerodynamicdiameter (PM10-PM2.5)
Jedrychowski WA 2012 [19], Liu C 2017 [20] Positive correlation withrisk of PTB
Polycyclic aromatic
hydrocarbons (PAHS)
Coal or fossil fuel, forest
fires, waste incineration,
Dong, X. 2018 [26]; Ferguson KK JAMA
pediatrics 2014 [24]; Padula AM 2014 [21];
Wilhelm M 2011 [22]; Guo Y 2012 [23]
PAHs concentration in
umbilical cord blood
correlates with negative
pregnancy outcomes
Drinking water
contaminants
Disinfection by-products,
atrazine
Grellier J 2010 [35], Hoffman CS 2008 [29];
Wright JM 2004 [33], Graves CG 2001 [36],
Tardiff RG 2006 [37], Jaakkola JJ 2001 [38],
Costet N 2012 [40], Horton BJ 2011 [41], Bove
FJ 1995 [42]; Aschengrau A 2008 [43]; Forand
SP 2011 [44], Rinsky JL 2012 [45]
Unclear correlation with
risk of PTB
Toxics 2019, 7, 11 10 of 16
Table 2. Cont.
Class of Toxic Chemicals Compounds References Findings
Persistent organic
compounds
Organochlorine
Compounds
Perfluoroalkylaed
substances
Porpora MG 2013 [54], Pathak R 2008 [55],
Wood SL 2007 [56], Tyagi V 2016 [59] Sagiv SK
2018 [61]
High concentration of
PCB in maternal and
fetal compartments
correlates with negative
pregnancy outcomes
Not persistent organic
compounds
Phthalates, Phenols, and
Parabens
Adibi JJ 2009 [64], Meeker JD 2009 [65],
Ferguson KK 2014 [24], Ferguson KK 2014 [25]
Unclear correlation with
risk of PTB
Tobacco smoke and
e-cigarettes
Nicotine, CO, cyanide,
aniline, methanol,
hydrogen sulfide,
arsenic, lead, cadmium.
Goldenberg RL 2008 [5], Lavezzi AM 2015 [60],
Crane J 2011 [69]; Qiu J 2014 [70]; Salmasi G
2010 [71]; Ion RC 2015 [72], Cnattingius S
2004 [73], Banowitz NL 2000 [74], Goldstein H
1964 [75], Hadley CB 1990 [76], Cui H 2016
[77], Miller RL 2004 [78], Behrooz L 2018 [79],
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Increasing risk of
PPROM, oxidative stress,
fetal growth restriction
Toxic Metals Lead, cadmium, mercury,arsenic Singh L 2018 [87], Chen Z 2001 [88]
Positive association with
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Global warming
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